Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Sharma, Padmanee, Hu-Lieskovan, Siwen, Wargo, Jennifer A., Ribas, Antoni·2017·Cell
DOI 10.1016/j.cell.2017.01.017

Cited by (125)

Items 101–125 of 125

  1. HDAC Inhibition to Prime Immune Checkpoint Inhibitors
    Borcoman, Edith, Kamal, Maud, Marret, Grégoire, Dupain, Celia, Castel-Ajgal, Zahra, Le Tourneau, Christophe · 2021 · Cancers
  2. Trial watch: immune checkpoint blockers for cancer therapy
    Vanpouille-Box, Claire, Lhuillier, Claire, Bezu, Lucillia, Aranda, Fernando, Yamazaki, Takahiro, Kepp, Oliver, Fucikova, Jitka, Spisek, Radek, Demaria, Sandra, Formenti, Silvia C. et al. · 2017 · OncoImmunology
  3. Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
    Ahronian, Leanne G., Corcoran, Ryan B. · 2017 · Genome Medicine
  4. Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
    Cai, Xin, Zhan, Huajie, Ye, Yuguang, Yang, Jinjin, Zhang, Minghui, Li, Jing, Zhuang, Yuan · 2021 · Frontiers in Genetics
  5. AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
    Sahin, Ilyas, Zhang, Shengliang, Navaraj, Arunasalam, Zhou, Lanlan, Dizon, Don, Safran, Howard, El-Deiry, Wafik S. · 2020 · Cell Death Discovery
  6. Cell Fate Reprogramming in the Era of Cancer Immunotherapy
    Zimmermannova, Olga, Caiado, Inês, Ferreira, Alexandra G., Pereira, Carlos-Filipe · 2021 · Frontiers in Immunology
  7. Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
    Borelli, Beatrice, Antoniotti, Carlotta, Carullo, Martina, Germani, Marco Maria, Conca, Veronica, Masi, Gianluca · 2022 · Cancers
  8. Dendritic cells as cancer therapeutics
    Bryant, Christian E., Sutherland, Sarah, Kong, Benjamin, Papadimitrious, Michael S., Fromm, Phillip D., Hart, Derek N.J. · 2019 · Seminars in Cell & Developmental Biology
  9. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1
    Obiedat, Akram, Seidel, Einat, Mahameed, Mohamed, Bernani, Orit, Tsukerman, Pinchas, Voutetakis, Konstantinos, Chatziioannou, Aristotelis, Mcmahon, Mari, Avril, Tony, Chevet, Eric et al. · 2019 · The FASEB Journal
  10. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
    Bassaganyas, Laia, Pinyol, Roser, Esteban-Fabró, Roger, Torrens, Laura, Torrecilla, Sara, Willoughby, Catherine E., Franch-Expósito, Sebastià, Vila-Casadesús, Maria, Salaverria, Itziar, Montal, Robert et al. · 2020 · Clinical Cancer Research
  11. Genomics and the Immune Landscape of Osteosarcoma
    Wu, Chia-Chin, Livingston, J. Andrew · 2020 · Advances in Experimental Medicine and Biology
  12. IL-17–induced HIF1α drives resistance to anti–PD-L1 via fibroblast-mediated immune exclusion
    Chen, Xing, Zhao, Junjie, Herjan, Tomasz, Hong, Lingzi, Liao, Yun, Liu, Caini, Vasu, Kommireddy, Wang, Han, Thompson, Austin, Fox, Paul L. et al. · 2022 · Journal of Experimental Medicine
  13. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
    Huang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen · 2022 · International Journal of Molecular Sciences
  14. Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
    Castello, Angelo, Rossi, Sabrina, Toschi, Luca, Lopci, Egesta · 2021 · Journal of Clinical Medicine
  15. Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients
    Pirozyan, Mehdi R., McGuire, Helen M., Emran, Abdullah Al, Tseng, Hsin-Yi, Tiffen, Jessamy C., Lee, Jenny H., Carlino, Matteo S., Menzies, Alexander M., Long, Georgina V., Scolyer, Richard A. et al. · 2020 · Frontiers in Immunology
  16. Epigenetic mechanisms of tumor resistance to immunotherapy
    Arenas-Ramirez, Natalia, Sahin, Dilara, Boyman, Onur · 2018 · Cellular and Molecular Life Sciences
  17. Functional differences between rodent and human PD-1 linked to evolutionary divergence
    Masubuchi, Takeya, Chen, Lin, Marcel, Nimi, Wen, George A., Caron, Christine, Zhang, Jibin, Zhao, Yunlong, Morris, Gerald P., Chen, Xu, Hedrick, Stephen M. et al. · 2025 · Science Immunology
  18. Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer
    Zhuo, Na, Liu, Chang, Zhang, Qi, Li, Jian, Zhang, Xiaotian, Gong, Jifang, Lu, Ming, Peng, Zhi, Zhou, Jun, Wang, Xicheng et al. · 2022 · JAMA Network Open
  19. TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Lin, Anqi, Zhang, Hongman, Meng, Hui, Deng, Ze, Gu, Tianqi, Luo, Peng, Zhang, Jian · 2021 · Frontiers in Immunology
  20. Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
    Mendes, Cindy, Serpa, Jacinta · 2019 · Antioxidants
  21. From serendipity to strategy: molecular glue degraders in cancer therapeutics
    Darling, Sarah, Bajrami, Ilirjana, West, Stephen C. · 2025 · Critical Reviews in Biochemistry and Molecular Biology
  22. Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers
    Goc, Jeremy, Sonnenberg, Gregory F. · 2022 · Cancer Immunology Research
  23. Next Generation T-Cell Therapy for Genitourinary Malignancies, Part A: Introduction and Current State of the Art
    Pantuck, Morgan, Palaskas, Nicolaos, Drakaki, Alexandra · 2018 · Cancer Treatment and Research Communications
  24. PathTIGR: A pathway topology-informed graph representation learning framework for immunotherapy response prediction
    Li X, He Y, Wu J, Wang Z, Zhao X, Zhang Y, Pan B, Tang Y, Han J · 2026 · PubMed
  25. An immune world model for multiscale forecasting and therapeutic hypothesis generation
    Cui, Taoyong, Wang, Xi, Li, Zonghang, Ding, Jinchao, You, Lingsen, Xu, Yuzhi, Xu, Wanghan, Wu, Fang, Ying, Kejun, Ouyang, Wanli et al. · 2026 · arXiv